Report copyright - Evolutec Group plc - Welcome to Nanoco Group Plc€¦ · Allergic rhinitis is the lead indication for our clinical development candidate rEV131. This $6.6 billion market represents
Please pass captcha verification before submit form
Please pass captcha verification before submit form